SK79893A3 - Pharmaceutical agent in form of solution for local administration into eye for treatment of enhanced inside eyes pressure - Google Patents

Pharmaceutical agent in form of solution for local administration into eye for treatment of enhanced inside eyes pressure Download PDF

Info

Publication number
SK79893A3
SK79893A3 SK798-93A SK79893A SK79893A3 SK 79893 A3 SK79893 A3 SK 79893A3 SK 79893 A SK79893 A SK 79893A SK 79893 A3 SK79893 A3 SK 79893A3
Authority
SK
Slovakia
Prior art keywords
eye
administration
pharmaceutical composition
solution
composition according
Prior art date
Application number
SK798-93A
Other languages
English (en)
Slovak (sk)
Inventor
Helmut Franz
Hannes E Kompa
Tibor Rozman
Original Assignee
Basotherm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basotherm Gmbh filed Critical Basotherm Gmbh
Publication of SK79893A3 publication Critical patent/SK79893A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
SK798-93A 1992-09-04 1993-07-28 Pharmaceutical agent in form of solution for local administration into eye for treatment of enhanced inside eyes pressure SK79893A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4229494A DE4229494A1 (de) 1992-09-04 1992-09-04 Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks

Publications (1)

Publication Number Publication Date
SK79893A3 true SK79893A3 (en) 1994-08-10

Family

ID=6467184

Family Applications (1)

Application Number Title Priority Date Filing Date
SK798-93A SK79893A3 (en) 1992-09-04 1993-07-28 Pharmaceutical agent in form of solution for local administration into eye for treatment of enhanced inside eyes pressure

Country Status (19)

Country Link
US (1) US5527831A (ja)
EP (1) EP0585896B1 (ja)
JP (1) JPH06172158A (ja)
KR (1) KR940006575A (ja)
CN (1) CN1086132A (ja)
AT (1) ATE145823T1 (ja)
AU (1) AU673533B2 (ja)
CA (1) CA2105530A1 (ja)
CZ (1) CZ284095B6 (ja)
DE (2) DE4229494A1 (ja)
DK (1) DK0585896T3 (ja)
ES (1) ES2096161T3 (ja)
GR (1) GR3022225T3 (ja)
HU (1) HU213272B (ja)
NO (1) NO933140L (ja)
NZ (1) NZ248567A (ja)
PL (1) PL300286A1 (ja)
SK (1) SK79893A3 (ja)
ZA (1) ZA936504B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
MY128762A (en) 2001-01-12 2007-02-28 Novartis Ag Lens care product containing dexpanthenol
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2005035969A (ja) * 2003-06-25 2005-02-10 Lion Corp 眼科用組成物及び該組成物の安定化方法
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
US9911989B2 (en) * 2005-07-25 2018-03-06 Bloom Energy Corporation Fuel cell system with partial recycling of anode exhaust
AU2008238577B2 (en) * 2007-04-12 2015-02-19 Waratah Pharmaceuticals Inc. Use of cyclohexanehexol derivatives in the treatment of ocular diseases
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
HUE049489T2 (hu) 2011-12-07 2020-09-28 Allergan Inc Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
PT72703B (en) * 1980-03-21 1982-11-15 Wellcome Found Stabilised ophtalmic formulation
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.

Also Published As

Publication number Publication date
AU4610593A (en) 1994-03-10
NZ248567A (en) 1995-11-27
ES2096161T3 (es) 1997-03-01
CZ181193A3 (en) 1994-07-13
GR3022225T3 (en) 1997-04-30
AU673533B2 (en) 1996-11-14
KR940006575A (ko) 1994-04-25
NO933140D0 (no) 1993-09-03
HUT64836A (en) 1994-03-28
EP0585896B1 (de) 1996-12-04
HU9302502D0 (en) 1993-11-29
ATE145823T1 (de) 1996-12-15
ZA936504B (en) 1995-03-03
CZ284095B6 (cs) 1998-08-12
NO933140L (no) 1994-03-07
DE4229494A1 (de) 1994-03-10
HU213272B (en) 1997-04-28
JPH06172158A (ja) 1994-06-21
PL300286A1 (en) 1994-03-07
US5527831A (en) 1996-06-18
EP0585896A1 (de) 1994-03-09
CN1086132A (zh) 1994-05-04
CA2105530A1 (en) 1994-03-05
DE59304658D1 (de) 1997-01-16
DK0585896T3 (da) 1997-04-14

Similar Documents

Publication Publication Date Title
EP0089815B1 (en) Liquid perfluorocarbons, for use in ocular therapy, and preparations containing them
EP0306984B1 (en) Preservative system for ophtalmic formulations
RU2130774C1 (ru) Фармацевтическая композиция для местного применения для лечения аллергических заболеваний глаз и носа
KR101961360B1 (ko) 신규한 요오드포 조성물 및 사용 방법
KR20070094600A (ko) 안질환 치료제
BG99213A (bg) Фармацевтичен състав за лечение на глаукома
SK79893A3 (en) Pharmaceutical agent in form of solution for local administration into eye for treatment of enhanced inside eyes pressure
KR100229842B1 (ko) 지속적 방출형 안과용 제제
KR20150032552A (ko) 치료 제제 및 치료 방법
GR1009040B (el) Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
KR100193406B1 (ko) 근시의 예방 및 치료용 조성물
EP1225890B1 (en) Rivastigmine for the treatment of ocular disorders
US6384084B2 (en) Histochrome and its therapeutic use in ophthalmology
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物
JPH1036255A (ja) 眼圧降下用点眼剤
AT407482B (de) Kalziumantagonistische augentropfen zur prophylaktischen behandlung der cataract
WO2024110503A1 (en) Methods for treating eyetear film deficiency
JP2741285B2 (ja) 緑内障治療剤
EP0456988B1 (en) Use of naproxen as mydriatic agent
Lamy et al. Physico-chemical aspects of ophthalmic and contact lens solutions
Nagasubramanian et al. The effects of a topical acetazolamide preparation on intraocular pressure in patients with ocular hypertension
JPH06511014A (ja) 眼への投与に用いる、緩衝剤系を含有するベラパミル塩酸製剤などの眼科用液剤